These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 29023526)
1. Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis. Gong X; Tang S; Li J; Zhang X; Tian X; Ma S PLoS One; 2017; 12(10):e0186449. PubMed ID: 29023526 [TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials. Lopes RD; Hong H; Harskamp RE; Bhatt DL; Mehran R; Cannon CP; Granger CB; Verheugt FWA; Li J; Ten Berg JM; Sarafoff N; Gibson CM; Alexander JH JAMA Cardiol; 2019 Aug; 4(8):747-755. PubMed ID: 31215979 [TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis. Capodanno D; Di Maio M; Greco A; Bhatt DL; Gibson CM; Goette A; Lopes RD; Mehran R; Vranckx P; Angiolillo DJ J Am Heart Assoc; 2020 Aug; 9(16):e017212. PubMed ID: 32805186 [TBL] [Abstract][Full Text] [Related]
4. Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy. Desai A; Escamilla-Ocanas C; Dilip D; Saber H; Damani R J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105654. PubMed ID: 33578352 [TBL] [Abstract][Full Text] [Related]
5. Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial. Kerneis M; Yee MK; Mehran R; Nafee T; Bode C; Halperin JL; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Cohen M; Fox KAA; Gibson CM Circ Cardiovasc Interv; 2019 Nov; 12(11):e008160. PubMed ID: 31707805 [TBL] [Abstract][Full Text] [Related]
6. Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. Park J; Jung JH; Choi EK; Lee SW; Kwon S; Lee SR; Kang J; Han KD; Park KW; Oh S; Lip GYH PLoS One; 2022; 17(2):e0264538. PubMed ID: 35213632 [TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. Kuno T; Ueyama H; Takagi H; Ando T; Numasawa Y; Briasoulis A; Fox J; Bangalore S Am J Cardiol; 2020 Feb; 125(4):521-527. PubMed ID: 31839147 [TBL] [Abstract][Full Text] [Related]
8. Non-Vitamin K Oral Anticoagulants (NOAC) Versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particular Focus on Combination Type. Eyileten C; Postula M; Jakubik D; Toma A; Mirowska-Guzel D; Patti G; Renda G; Siller-Matula JM J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32295160 [TBL] [Abstract][Full Text] [Related]
9. Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis. Lopes RD; Hong H; Harskamp RE; Bhatt DL; Mehran R; Cannon CP; Granger CB; Verheugt FWA; Li J; Ten Berg JM; Sarafoff N; Vranckx P; Goette A; Gibson CM; Alexander JH JAMA Cardiol; 2020 May; 5(5):582-589. PubMed ID: 32101251 [TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes of Antithrombotic Strategies for Patients with Atrial Fibrillation After Percutaneous Coronary Intervention. Gao X; Ge Z; Kong X; Wang Z; Zuo G; Wang F; Chen S; Zhang J Int Heart J; 2019 May; 60(3):546-553. PubMed ID: 31105152 [TBL] [Abstract][Full Text] [Related]
11. Network meta-analysis of efficacy and safety of competitive oral anticoagulants in patients undergoing radiofrequency catheter ablation of atrial fibrillation. Li PJ; Xiao J; Yang Q; Feng Y; Wang T; Liu GJ; Liang ZA J Interv Card Electrophysiol; 2016 Sep; 46(3):213-24. PubMed ID: 27001171 [TBL] [Abstract][Full Text] [Related]
12. Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. Gibson CM; Mehran R; Bode C; Halperin J; Verheugt FW; Wildgoose P; Birmingham M; Ianus J; Burton P; van Eickels M; Korjian S; Daaboul Y; Lip GY; Cohen M; Husted S; Peterson ED; Fox KA N Engl J Med; 2016 Dec; 375(25):2423-2434. PubMed ID: 27959713 [TBL] [Abstract][Full Text] [Related]
13. Comparative Safety and Efficacy of Eight Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. Liang B; Zhu YC; Gu N Front Cardiovasc Med; 2022; 9():832164. PubMed ID: 35387437 [TBL] [Abstract][Full Text] [Related]
14. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials? Duerschmied D; Brachmann J; Darius H; Frey N; Katus HA; Rottbauer W; Schäfer A; Thiele H; Bode C; Zeymer U Clin Res Cardiol; 2018 Jul; 107(7):533-538. PubMed ID: 29679144 [TBL] [Abstract][Full Text] [Related]
15. [Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Atrial Fibrillation]. Darius H Dtsch Med Wochenschr; 2020 Jul; 145(14):978-986. PubMed ID: 32668469 [TBL] [Abstract][Full Text] [Related]
16. Use and Outcomes of Triple Antithrombotic Therapy with Non-Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. Casamira N; García-Camarero T; Montoro-Ronsano JB; Veiga G; Del Blanco BG; De La Torre JM; Gordon B; García-Dorado D; Sambola A Am J Med Sci; 2019 Aug; 358(2):95-103. PubMed ID: 31176420 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of non-vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial. Chi G; Kerneis M; Kalayci A; Liu Y; Mehran R; Bode C; Halperin JL; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Cohen M; Peterson ED; Fox KAA; Gibson CM Am Heart J; 2018 Sep; 203():17-24. PubMed ID: 30015064 [TBL] [Abstract][Full Text] [Related]
18. Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry. Xanthopoulou I; Dragona VM; Davlouros P; Tsioufis C; Iliodromitis E; Alexopoulos D; Cardiovasc Drugs Ther; 2018 Apr; 32(2):191-196. PubMed ID: 29679301 [TBL] [Abstract][Full Text] [Related]
19. Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions: meta-analysis of pooled data from the PIONEER AF-PCI, RE-DUAL PCI, and AUGUSTUS trials. Potpara TS; Mujovic N; Proietti M; Dagres N; Hindricks G; Collet JP; Valgimigli M; Heidbuchel H; Lip GYH Europace; 2020 Jan; 22(1):33-46. PubMed ID: 31603196 [TBL] [Abstract][Full Text] [Related]
20. Network Meta-Analysis of Initial Antithrombotic Regimens After Left Atrial Appendage Occlusion. Carvalho PEP; Gewehr DM; Miyawaki IA; Nogueira A; Felix N; Garot P; Darmon A; Mazzone P; Preda A; Nascimento BR; Kubrusly LF; Cardoso R J Am Coll Cardiol; 2023 Oct; 82(18):1765-1773. PubMed ID: 37611779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]